Liver Cancer

Medicine & Life Sciences

1. Hepatocellular Carcinoma 100%
2. Liver 63%
3. Fibrosis 43%
4. Hepatic Stellate Cells 41%
5. Liver Transplantation 38%
6. Neoplasms 25%
7. Liver Cirrhosis 24%
8. Hepacivirus 20%
9. Liver Diseases 19%
10. Survival 17%
11. Sorafenib 15%
12. Liver Neoplasms 15%
13. Therapeutics 14%
14. Hepatitis C 14%
15. Cholangiocarcinoma 14%
16. Non-alcoholic Fatty Liver Disease 13%
17. Biomarkers 10%
18. Recurrence 9%
19. Fatty Liver 9%
20. Wounds and Injuries 9%
21. Living Donors 9%
22. Hepatocytes 8%
23. Genes 8%
24. Transplants 8%
25. Kruppel-Like Factor 6 7%
26. Transplantation 6%
27. Mutation 6%
28. gadolinium ethoxybenzyl DTPA 6%
29. Elasticity Imaging Techniques 6%
30. Chronic Disease 6%
31. Collagen 6%
32. Transforming Growth Factors 6%
33. Magnetic Resonance Imaging 6%
34. ramucirumab 6%
35. Tissue Donors 5%
36. alpha-Fetoproteins 5%
37. Extracellular Matrix 5%
38. Clinical Trials 5%
39. Neoplasm Metastasis 5%
40. Chronic Hepatitis C 5%
41. Proteins 5%
42. Response Evaluation Criteria in Solid Tumors 5%
43. Virus Diseases 5%
44. Portal Hypertension 5%
45. Autophagy 5%